Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yoghurt

International Dairy Journal

Volumn 16, Issue 10, 2006, Pages 1174-1180

  Mättö, Jaana ^a   Fondén, Rangne ^b   Tolvanen, Tiina ^c   von Wright, Atte ^c   Vilpponen Salmela, Terttu ^d   Satokari, Reetta ^a   Saarela, Maria ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b Arla Foods   (Denmark)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Harjula Hospital   (Finland)

Author keywords

Bifidobacterium; Faecal microbiota; Lactobacillus; Mucosal biopsy; Yoghurt

Indexed keywords

BIOPSY; CELL CULTURE; DNA; GASTROENTEROLOGY; MICROBIOLOGY;

BIFIDOBACTERIUM; FAECAL MICROBIOTA; LACTOBACILLUS; MUCOSAL BIOPSY; YOGHURT;

BACTERIA;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS;

EID: 33744990368     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2005.10.007     Document Type: Article

References (28)

1. Alander M., Mättö J., Kneifel W., Johansson M., Kögler B., Crittenden R., et al. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. International Dairy Journal 11 (2001) 817-825
2. Beerens H. Detection of bifidobacteria by using propionic acid as a selective agent. Applied and Environmental Microbiology 57 (1991) 2418-2419
3. Brigidi P., Vitali B., Swennen E., Bazzocchi G., and Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Research in Microbiology 152 (2001) 735-741
4. Crittenden R., Saarela M., Mättö J., Ouwehand A.C., Salminen S., Pelto L., et al. Lactobacillus paracasei subsp. paracasei isolate F19: Survival, ecology and safety in the human intestinal tract-a survey of feeding studies within the PROBDEMO project. Microbial Ecology in Health and Disease 3 Suppl. (2002) 22-26
5. Fukushima Y., Kawata Y., Hara H., Terada A., and Mitsuoka T. Effect of probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology 42 (1998) 39-44
6. Gionchetti P., Rizzello F., Venturi A., Birigidi P., Matteuzzi D., Bazzocchi G., et al. Oral bacteriotherapy as a maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119 (2000) 305-309
7. Glück U., and Gebbers J.-O. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). American Journal of Clinical Nutrition 77 (2003) 517-520
8. Isolauri E., Salminen S., and Ouwehand A.C. Probiotics. Best Practice & Research Clinical Gastroenterology 18 (2004) 299-313
9. Kiessling G., Schneider J., and Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholestrol. European Journal of Clinical Nutrition 56 (2002) 843-849
10. Laake K.O., Line P.D., Aabakken L., Lotveit T., Bakka A., Eide J., et al. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scandinavian Journal of Gastroenterology 38 (2003) 409-414
11. Lappalainen R., Kearney J., and Gibney M. A pan EU survey of consumer attitudes to food, nutrition and health: An overview. Food Quality and Preference 9 (1998) 467-478
12. Lidbeck A., Edlund C., Gustafsson J.-A., Kager L., and Nord C.E. Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents. Infection 16 (1988) 329-336
13. Lidbeck A., Gustafsson J.-A., and Nord C.E. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora. Scandinavian Journal of Infectious Diseases 19 (1987) 531-537
14. Menrad K. Market and marketing of functional food in Europe. Journal of Food Engineering 56 (2003) 181-188
15. Oberreuther-Moschner D.L., Jahreis G., Rechkemmer G., and Pool-Zobel B.L. Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. British Journal of Nutrition 91 (2004) 925-932
16. Orrhage K., Sjlöstedt S., and Nord C.E. Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. Journal of Antimicrobial Chemotherapy 46 (2000) 603-611
17. Rosenfeldt V., Paerregaard A., Larsen C.N., Moller P.L., Tvede M., Sandstrom B., et al. Faecal recovery, mucosal adhesion, gastrointestinal effects and tolerance of mixed cultures of potential probiotic lactobacilli. Microbial Ecology in Health and Disease 5 (2003) 2-9
18. Salminen S., Bouley C., Boutron-Ruault M.-C., Cummings J.H., Franck A., Gibson G.R., et al. Functional food science and gastrointestinal physiology and function. British Journal of Nutrition 80 Suppl. 1 (1998) S147-S171
19. Sheu B.S., Wu J.J., Lo C.Y., Wu H.W., Chen J.H., Lin Y.S., et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 16 (2002) 1669-1675
20. Sullivan A., Barkholt L., and Nord C.E. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. Journal of Antimicrobial Chemotherapy 52 (2003) 308-311
21. Sullivan A., Bennet R., Viitanen M., Palmgren A.-C., and Nord C.E. Influence of Lactobacillus F19 on intestinal microflora in children and elderly persons and impact on Helicobacter pylori infections. Microbial Ecology in Health and Disease Suppl. 3 (2002) 17-21
22. Sullivan A., Johansson A., Svenungsson B., and Nord C.E. Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora. Journal of Antimicrobial Chemotherapy 54 (2004) 791-797
23. Sullivan A., and Nord C.E. Probiotics and gastrointestinal diseases. Journal of Internal Medicine 257 (2005) 78-92
24. Sullivan A., Palmgren A.-C., and Nord C.E. Effect of Lactobacillus paracasei on intestinal colonisation of lactobacilli, bifidobacteria and Clostridium difficile in elderly persons. Anaerobe 7 (2001) 67-70
25. Sutter, V., Citron, D., Edelstein, M., & Finegold, S. (1985). Wadsworth anaerobe bacteriology manual (4th ed., p. 109). USA: Star.
26. Timmerman H.M., Koning C.J.M., Mulder L., Rombouts F.M., and Beynen A.C. Monostrain, multistrain and multispecies probiotics-a comparison of functionality and efficacy. International Journal of Food Microbiology 96 (2004) 219-233
27. Venturi A., Ginchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., et al. Impact of the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 13 (1999) 1103-1108
28. Wang K.-Y., Li S.-N., Liu C.-S., Perng D.-S., Su Y.-C., Wu D.-C., et al. Effects if ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. American Journal of Clinical Nutrition 80 (2004) 737-741